Header Logo

Connection

Srinivas Vourganti to Urinary Bladder Neoplasms

This is a "connection" page, showing publications Srinivas Vourganti has written about Urinary Bladder Neoplasms.
Connection Strength

0.403
  1. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer. Mol Cancer Ther. 2017 10; 16(10):2201-2214.
    View in: PubMed
    Score: 0.144
  2. Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. Urol Oncol. 2015 Apr; 33(4):167.e13-20.
    View in: PubMed
    Score: 0.123
  3. Estrogen receptor-? expression and pharmacological targeting in bladder cancer. Oncol Rep. 2013 Jul; 30(1):131-8.
    View in: PubMed
    Score: 0.108
  4. Adverse health outcomes associated with surgical management of the small renal mass. J Urol. 2014 Feb; 191(2):301-8.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.